AstraZeneca continues hunt for RNA-based therapies

04/2/2013 | Bloomberg

AstraZeneca CEO Pascal Soriot is forging ahead with efforts to discover drugs based on RNA technology with its partnership with biotech company Moderna Therapeutics. Moderna's platform allows fast, simultaneous testing on multiple targets for messenger RNA. The company is also working on antisense therapies in partnership with Isis Pharmaceuticals.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Director, Medicare Advantage/Medicare Part D Focus
Avalere Health
Washington, DC
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI